Authors
Latest:
Rising sea level: The transportation of pharmaceuticals by sea continues to gain momentum in the quest for greater supply chain resilienceWhen shipping pharmaceuticals internationally, the decision of ocean shipping versus air shipping might seem obvious if the speed of air shipping is the only factor at play when sending sensitive medical supplies and drugs. For the last several years, however, more companies have decided to embrace ocean shipping as a means of delivering their medicines. Industry experts Alan Kennedy and Allan Klinge discuss how, with more cold chain control, a lower carbon footprint and lower costs, ocean-going vessels often have clear advantages over air freight.
Latest:
Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions BusinessThe newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
Latest:
Study Highlights PBMs’ Role in Drug PricesAn analysis by 3 Axis Advisors has found that there is a large variability in pharmacy reimbursement of prescription drugs depending on PBM contracts with insurers. This creates a system with huge inconsistencies on the prices of both generics and branded products.
Latest:
Pharma Pulse 5/17/24: Apple Watch's Afib App certified by FDA, Learning Telehealth Platforms Benefits Pharmacy Students & moreThe latest news for pharma industry insiders.
Latest:
Mark Cuban’s Cost Plus Drugs Partners with Price.comThe two company’s will provide consumers with a platform where they can compare drug prices.
Latest:
Continued Affordability Challenges in the OffingWill result from Medicare reforms, despite increased drug uptake.
Latest:
Raising the stakes for market access supportCase study on closing the gap between new specialty drugs and specialty pharmacies
Latest:
How to Maximize Pharmacy Reimbursement for Every Order and Prevent Costly Write-OffsQuestions pharmacies should ask when choosing the right proof-of-delivery solution
Latest:
Beyond Payment MethodsThe need for supporting services in copay accumulator and best price areas
Latest:
The Importance of Having the Biopharma Industry Join the Journey to Net-Zero EmissionsHow setting action-based goals and cultivating partnerships will help overcome challenges associated with implementing a sustainable GHG strategy.
Latest:
Democratizing AI: Bridging the Intelligence Divide in Commercial Life SciencesSmall and emerging biopharma have been historically reserved about artificial intelligence. But, writes Alan Kalton, AI solutions have matured, been proven, and are no longer a risky investment for small to mid-size companies.
Latest:
Realistic Net-Zero Goals for PharmaHow temperature-controlled containers can play key role in the industry's mission for carbon neutrality across the supply chain.
Latest:
What Will Change in the Pharma Industry Look Like?Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).
Latest:
What Health & Wellness Companies Need to Know About the New Provider/Patient RelationshipHow has the provider-patient relationship transformed over the past two years, and what care are consumers craving?
Latest:
Pharma's Journey with Patient Family Advisory CouncilsIncluding patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.
Latest:
Creating Value from Compliance DataHow maximizing the intelligence gained from brand engagement compliance activities can help drive pharmaceutical company commercial decisions.
Latest:
Streamlining for Safety: Navigating Changes and Trends in the Pharmaceutical Supply Chain Post-DSCSAWith its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain.
Latest:
Climbing Health Care Costs Result in Elevated Employer VigilanceSoaring healthcare costs show little sign of abating in 2024, and concerns about the affordability of medications and medical services continue to grow, despite investments in technology, clinical innovation, and efforts to manage utilization and waste.
Latest:
Strategic EPCIS Implementation: Optimizing Supply Chain Management through Strategic EPCIS ImplementationThis document outlines key strategies and testing protocols critical for optimizing EPCIS implementation, ensuring that pharmaceutical manufacturers can maintain compliance and operational efficiency.
Latest:
Preparing for the Growth of Cold ChainCardinal Health helps create a more predictable and efficient supply chain by investing in the future of cold-chain storage and transportation.
Latest:
The Promise of RFID for Improving Medication Inventory ManagementRadio frequency identification (RFID) not only helps hospitals boost their medication safety standards, it also allows clinicians to continue to provide quality patient care.
Latest:
The Future State of Oncology: The Rise of Oncology Home CareWhile there are still hurdles to overcome along the way, home healthcare could deliver better patient-centered cancer care, providing improved patient outcomes, enhanced quality of life, and reduced strain on resources.
Latest:
What Do Pharmaceutical Manufacturers Actually Want Most from a Hub?Among a variety of Hub vendors, what specific qualities distinguish differentiated support for drug manufacturers? To help answer this question, CareMetx conducted in-depth interviews and surveys with senior leadership at top manufacturers.
Latest:
New Serialization Mandates Inch CloserPressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance
Latest:
Evaluating Patient Support Programs: Opportunities and PitfallsAssessing the efficacy of patient support programs is the first step to optimizing their resource allocation and program design for maximized patient benefit.
Latest:
Key Supply Chain Tech Trends for 2023Outlining those advances poised to drive increased use of integrated tactical planning (ITP) in helping manufacturers overcome persistent supply chain obstacles.
Latest:
FDA Issues Complete Response Letter to Abeona Therapeutics Regarding PZ-Cel for Recessive Dystrophic Epidermolysis BullosaCiting a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly.
Latest:
A Game Changer for Commercial Insights?Configuration-driven SaaS, powered by modern data management technology, can enable orphan drug manufacturers to form effective commercial strategies
Latest:
Specialty access barriers: How technology can help2020 was a difficult year for many patients, but new data may signal a brighter future ahead
